{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T23:54:28Z","timestamp":1784159668957,"version":"3.55.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ijcard.2016.03.084","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T23:15:43Z","timestamp":1458861343000},"page":"265-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"212","author":[{"given":"Els","family":"Vandecasteele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"De Pauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"De Keyser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Decuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Deschepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Piette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Brusselle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijcard.2016.03.084_bb0005","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ijcard.2016.03.084_bb0010","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR scleroderma trials and research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ijcard.2016.03.084_bb0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Authors\/Task Force M","year":"2016","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ijcard.2016.03.084_bb0020","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1445-5994.2008.01823.x","article-title":"Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis","volume":"39","author":"Phung","year":"2009","journal-title":"Intern Med J"},{"issue":"12","key":"10.1016\/j.ijcard.2016.03.084_bb0025","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ijcard.2016.03.084_bb0030","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.30541","article-title":"Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival","volume":"63","author":"Humbert","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ijcard.2016.03.084_bb0035","first-page":"919","article-title":"The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure","volume":"132","author":"Guyatt","year":"1985","journal-title":"Can Med Assoc J"},{"issue":"1","key":"10.1016\/j.ijcard.2016.03.084_bb0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","author":"Laboratories ATSCoPSfCPF","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.ijcard.2016.03.084_bb0045","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3899\/jrheum.081221","article-title":"Lack of specificity of the 6-minute walk test as an outcome measure for patients with systemic sclerosis","volume":"36","author":"Schoindre","year":"2009","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.ijcard.2016.03.084_bb0050","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1183\/09031936.00150414","article-title":"An official systematic review of the European Respiratory Society\/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease","volume":"44","author":"Singh","year":"2014","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ijcard.2016.03.084_bb0055","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1183\/09031936.00150314","article-title":"An official European Respiratory Society\/American Thoracic Society technical standard: field walking tests in chronic respiratory disease","volume":"44","author":"Holland","year":"2014","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.ijcard.2016.03.084_bb0060","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ijcard.2016.03.084_bb0065","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/art.30423","article-title":"Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies","volume":"63","author":"Le Pavec","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ijcard.2016.03.084_bb0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3899\/jrheum.080447","article-title":"Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma","volume":"36","author":"Garin","year":"2009","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.ijcard.2016.03.084_bb0075","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2009.120303","article-title":"Validation of the 6min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT group","volume":"69","author":"Avouac","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ijcard.2016.03.084_bb0080","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/ard.2007.077149","article-title":"Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials","volume":"67","author":"Avouac","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ijcard.2016.03.084_bb0085","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/art.23718","article-title":"Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis","volume":"59","author":"Distler","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ijcard.2016.03.084_bb0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/annrheumdis-2012-202567","article-title":"Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis","volume":"73","author":"Avouac","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.ijcard.2016.03.084_bb0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ijcard.2016.03.084_bb0100","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.ijcard.2016.03.084_bb0105","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ijcard.2016.03.084_bb0110","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1378\/chest.10-2473","article-title":"Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease","volume":"140","author":"Launay","year":"2011","journal-title":"Chest"},{"issue":"4 Suppl 91","key":"10.1016\/j.ijcard.2016.03.084_bb0115","first-page":"S142","article-title":"Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease","volume":"33","author":"Rizzi","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.ijcard.2016.03.084_bb0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/ard.2006.054866","article-title":"Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test","volume":"66","author":"Buch","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ijcard.2016.03.084_bb0125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/rheumatology\/kel221","article-title":"Validity of the Saint George's respiratory questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis","volume":"46","author":"Beretta","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.ijcard.2016.03.084_bb0130","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10067-008-0837-9","article-title":"Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis","volume":"27","author":"Ciurzynski","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.ijcard.2016.03.084_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027993","article-title":"Assessment of daily life physical activities in pulmonary arterial hypertension","volume":"6","author":"Mainguy","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijcard.2016.03.084_bb0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ijcard.2016.03.084_bb0145","series-title":"R Foundation for Statistical Computing, Vienna, Austria","article-title":"R: A language and environment for statistical computing","author":"Core Team","year":"2014"},{"issue":"9","key":"10.1016\/j.ijcard.2016.03.084_bb0150","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/art.38029","article-title":"Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis","volume":"65","author":"Lefevre","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.ijcard.2016.03.084_bb0155","first-page":"235","article-title":"Evaluation of the functional parameters in scleroderma cases with pulmonary involvement","volume":"58","author":"Celebi Sozener","year":"2010","journal-title":"Tuberk Toraks"},{"issue":"6","key":"10.1016\/j.ijcard.2016.03.084_bb0160","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10067-013-2204-8","article-title":"Organ involvement in Argentinian systemic sclerosis patients with \u201clate\u201d pattern as compared to patients with \u201cearly\/active\u201d pattern by nailfold capillaroscopy","volume":"32","author":"Marino Claverie","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.ijcard.2016.03.084_bb0165","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0954-6111(03)00254-3","article-title":"Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension","volume":"97","author":"Mukerjee","year":"2003","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.ijcard.2016.03.084_bb0170","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10554-014-0583-9","article-title":"Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance","volume":"31","author":"Cadeddu","year":"2015","journal-title":"Int J Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ijcard.2016.03.084_bb0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/bjpt-rbf.2014.0084","article-title":"Lower limb muscle strength is associated with functional performance and quality of life in patients with systemic sclerosis","volume":"19","author":"Lima","year":"2015","journal-title":"Braz J Phys Ther"},{"issue":"3","key":"10.1016\/j.ijcard.2016.03.084_bb0180","first-page":"269","article-title":"Assessment of left and right ventricular diastolic function in patients with systemic sclerosis","volume":"66","author":"Ciurzynski","year":"2008","journal-title":"Kardiol Pol"},{"issue":"2","key":"10.1016\/j.ijcard.2016.03.084_bb0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00296-010-1557-4","article-title":"Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study","volume":"31","author":"Dimitroulas","year":"2011","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.ijcard.2016.03.084_bb0190","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/art.27466","article-title":"Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis","volume":"62","author":"Seibold","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.ijcard.2016.03.084_bb0195","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.22069","article-title":"Clinical differences between idiopathic and scleroderma-related pulmonary hypertension","volume":"54","author":"Fisher","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ijcard.2016.03.084_bb0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.semarthrit.2014.03.002","article-title":"Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS) cohort study","volume":"44","author":"Hsu","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ijcard.2016.03.084_bb0205","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/rheumatology\/ken346","article-title":"Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension","volume":"47","author":"Dimitroulas","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.ijcard.2016.03.084_bb0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MD.0000000000000032","article-title":"Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans","volume":"93","author":"Blanco","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.ijcard.2016.03.084_bb0215","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/annrheumdis-2011-200546","article-title":"Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry","volume":"71","author":"Bae","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ijcard.2016.03.084_bb0220","first-page":"2252","article-title":"Aerosolized iloprost in CREST syndrome related pulmonary hypertension","volume":"28","author":"Launay","year":"2001","journal-title":"J Rheumatol"},{"issue":"2 Suppl 65","key":"10.1016\/j.ijcard.2016.03.084_bb0225","first-page":"S53","article-title":"Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis","volume":"29","author":"Deuschle","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"2 Suppl 76","key":"10.1016\/j.ijcard.2016.03.084_bb0230","first-page":"18","article-title":"Six-minute walk test reflects neurohormonal activation and right ventricular function in systemic sclerosis patients","volume":"31","author":"Irzyk","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.ijcard.2016.03.084_bb0235","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1445-5994.2008.01880.x","article-title":"The six-minute walk test: a useful metric for the cardiopulmonary patient","volume":"39","author":"Rasekaba","year":"2009","journal-title":"Intern Med J"},{"issue":"25 Suppl.","key":"10.1016\/j.ijcard.2016.03.084_bb0240","doi-asserted-by":"crossref","first-page":"D73","DOI":"10.1016\/j.jacc.2013.10.034","article-title":"Treatment goals of pulmonary hypertension","volume":"62","author":"McLaughlin","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ijcard.2016.03.084_bb0245","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1440-1843.2012.02133.x","article-title":"The six-minute walk test using forehead oximetry is reliable in the assessment of scleroderma lung disease","volume":"17","author":"Wilsher","year":"2012","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.ijcard.2016.03.084_bb0250","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/acr.20448","article-title":"Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis","volume":"63","author":"Schouffoer","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.ijcard.2016.03.084_bb0255","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10067-008-1006-x","article-title":"An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility","volume":"28","author":"Antonioli","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"5 Pt 1","key":"10.1016\/j.ijcard.2016.03.084_bb0260","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/ajrccm.158.5.9710086","article-title":"Reference equations for the six-minute walk in healthy adults","volume":"158","author":"Enright","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ijcard.2016.03.084_bb0265","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jbmt.2014.01.002","article-title":"Relationship between functional capacity, joint mobility and pulmonary function in patients with systemic sclerosis","volume":"19","author":"Lima","year":"2015","journal-title":"J Bodyw Mov Ther"},{"issue":"6","key":"10.1016\/j.ijcard.2016.03.084_bb0270","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.ijcard.2016.03.084_bb0275","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1183\/09031936.00238514","article-title":"ERS guidelines, statements and technical standards published in the ERJ in 2014: a year in review","volume":"45","author":"Brusselle","year":"2015","journal-title":"Eur Respir J"},{"issue":"4 Suppl 91","key":"10.1016\/j.ijcard.2016.03.084_bb0280","first-page":"S106","article-title":"Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China","volume":"33","author":"Zhang","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.ijcard.2016.03.084_bb0285","first-page":"156","article-title":"Circulating adipokines and organ involvement in patients with systemic sclerosis","volume":"40","author":"Olewicz-Gawlik","year":"2015","journal-title":"Acta Reumatol Port"},{"issue":"4","key":"10.1016\/j.ijcard.2016.03.084_bb0290","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5005\/ijcdas-56-4-231","article-title":"A study on pulmonary complications of systemic sclerosis in eastern India","volume":"56","author":"Ghosh","year":"2014","journal-title":"Indian J Chest Dis Allied Sci"},{"issue":"2","key":"10.1016\/j.ijcard.2016.03.084_bb0295","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/rheumatology\/ket331","article-title":"Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension","volume":"53","author":"Ruiter","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.ijcard.2016.03.084_bb0300","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1136\/annrheumdis-2012-202489","article-title":"Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era","volume":"72","author":"Launay","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ijcard.2016.03.084_bb0305","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00296-012-2466-5","article-title":"Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications","volume":"33","author":"Kumar","year":"2013","journal-title":"Rheumatol Int"},{"issue":"12","key":"10.1016\/j.ijcard.2016.03.084_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014293","article-title":"Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing","volume":"5","author":"Dumitrescu","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijcard.2016.03.084_bb0315","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1183\/09031936.00074309","article-title":"Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension","volume":"35","author":"Mathai","year":"2010","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ijcard.2016.03.084_bb0320","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/rheumatology\/kep398","article-title":"Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil","volume":"49","author":"Launay","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.ijcard.2016.03.084_bb0325","first-page":"461","article-title":"Functional assessment of patients with systemic sclerosis by the use of \u2018six-minutes-walking-test\u2019","volume":"160","author":"Coaccioli","year":"2009","journal-title":"Clin Ter"},{"issue":"5","key":"10.1016\/j.ijcard.2016.03.084_bb0330","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1378\/chest.08-3042","article-title":"Is pulmonary arterial hypertension really a late complication of systemic sclerosis?","volume":"136","author":"Hachulla","year":"2009","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ijcard.2016.03.084_bb0335","first-page":"1012","article-title":"Lack of correlation of the health assessment questionnaire disability index with lung parameters in systemic sclerosis associated pulmonary arterial hypertension","volume":"26","author":"Chow","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.ijcard.2016.03.084_bb0340","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1378\/chest.06-0630","article-title":"Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients","volume":"131","author":"Villalba","year":"2007","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ijcard.2016.03.084_bb0345","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2006.08.070","article-title":"Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension","volume":"121","author":"Dimitroulas","year":"2007","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2016.03.084_bb0350","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1183\/09031936.00081706","article-title":"Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension","volume":"29","author":"Mathai","year":"2007","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ijcard.2016.03.084_bb0355","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1378\/chest.06-1401","article-title":"Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life","volume":"131","author":"Camiciottoli","year":"2007","journal-title":"Chest"},{"issue":"Suppl. 3","key":"10.1016\/j.ijcard.2016.03.084_bb0360","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2362.2006.01684.x","article-title":"Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases","volume":"36","author":"Cozzi","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"Suppl. 3","key":"10.1016\/j.ijcard.2016.03.084_bb0365","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2362.2006.01695.x","article-title":"Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease","volume":"36","author":"Ahmadi-Simab","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.ijcard.2016.03.084_bb0370","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1378\/chest.130.1.182","article-title":"Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension","volume":"130","author":"Sanchez","year":"2006","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.ijcard.2016.03.084_bb0375","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/eurheartj\/ehi891","article-title":"Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension","volume":"27","author":"Williams","year":"2006","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ijcard.2016.03.084_bb0380","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/hrt.2005.069484","article-title":"Systemic sclerosis associated pulmonary hypertension: improved survival in the current era","volume":"92","author":"Williams","year":"2006","journal-title":"Heart"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731630506X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731630506X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:39:33Z","timestamp":1759091973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752731630506X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":76,"alternative-id":["S016752731630506X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.084","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.03.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}